These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


925 related items for PubMed ID: 31057302

  • 1. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y, Xu HF, Liu MY, Xu YJ, He JC, Zhou Y, Cang SD.
    World J Gastroenterol; 2019 Apr 21; 25(15):1890-1898. PubMed ID: 31057302
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X, Zhao Y, Wang X, Qin L, Hu R.
    J Cell Biochem; 2019 Jan 21; 120(1):135-142. PubMed ID: 30238497
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W, Ding X, Wang S, Xu L, Yin T, Han S, Geng J, Sun W.
    J Clin Lab Anal; 2020 Jun 21; 34(6):e23239. PubMed ID: 32125733
    [Abstract] [Full Text] [Related]

  • 4. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M, Jiang Y, Yang L, Yan S, Wang YG, Lu XJ.
    J Cell Biochem; 2018 Jun 21; 119(6):4711-4716. PubMed ID: 29278659
    [Abstract] [Full Text] [Related]

  • 5. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G, Zhao W, Wang H, Qiu G, Jiang Z, Wei G, Li X.
    Med Sci Monit; 2019 Sep 25; 25():7209-7217. PubMed ID: 31553714
    [Abstract] [Full Text] [Related]

  • 6. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
    Yokota Y, Noda T, Okumura Y, Kobayashi S, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Takeda Y, Tanemura M, Murakami T, Umeshita K, Doki Y, Eguchi H.
    Cancer Sci; 2021 Mar 25; 112(3):1275-1288. PubMed ID: 33426736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
    Xue X, Wang X, Zhao Y, Hu R, Qin L.
    Biochem Biophys Res Commun; 2018 Aug 25; 502(4):515-521. PubMed ID: 29859935
    [Abstract] [Full Text] [Related]

  • 9. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, Lee HW, Han YS, Chun JM, Park SY, Hur K.
    Int J Cancer; 2019 Mar 15; 144(6):1444-1452. PubMed ID: 30338850
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX, Zhang BL, Yang Y, Wang MC, Lei GL, Gao Y, Liu H, Xiao CH, Xu JJ, Qin H, Xu XY, Chen ZS, Zhang DD, Li FG, Zhang SG, Liu R.
    Oncol Rep; 2019 Jan 15; 41(1):257-269. PubMed ID: 30542726
    [Abstract] [Full Text] [Related]

  • 14. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.
    Wang H, Hou L, Li A, Duan Y, Gao H, Song X.
    Biomed Res Int; 2014 Jan 15; 2014():864894. PubMed ID: 24963487
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X, Zhang J, Zhou L, Lu P, Zheng ZG, Sun W, Wang JL, Yang XS, Li XL, Xia N, Zhang N, Dou KF.
    Int J Clin Exp Pathol; 2015 Jan 15; 8(2):1466-78. PubMed ID: 25973032
    [Abstract] [Full Text] [Related]

  • 17. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L, Chu F, Cao Y, Shao J, Wang F.
    Tumour Biol; 2015 Sep 15; 36(10):7439-47. PubMed ID: 25903466
    [Abstract] [Full Text] [Related]

  • 18. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
    Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW.
    Cancer Med; 2020 Aug 15; 9(15):5459-5472. PubMed ID: 32537885
    [Abstract] [Full Text] [Related]

  • 19. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, Yun JP, Xu RH, Cai QQ, Xie D.
    Theranostics; 2019 Aug 15; 9(7):1965-1979. PubMed ID: 31037150
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
    Cao C, Wang C.
    Clin Exp Med; 2020 Nov 15; 20(4):569-576. PubMed ID: 32712720
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.